Drug targets in malaria parasites

Area of Science:

• Medical Parasitology
• Drug Discovery
• Tropical Medicine

Background:

• Malaria causes significant global health burdens, with millions of cases annually in India.
• Increasing resistance to current antimalarials like chloroquine necessitates the development of new drugs.
• The economic impact of malaria, through morbidity and lost productivity, is substantial, particularly in developing nations.

Purpose of the Study:

• To review novel drug targets within the malaria parasite's metabolic pathways.
• To highlight research efforts in India focused on identifying new antimalarial pharmacophores.
• To address the urgent need for new, affordable antimalarial treatments.

Main Methods:

• Review of existing scientific literature on malaria parasite biology and drug targets.
• Analysis of research trends in antimalarial drug discovery, with a focus on Indian contributions.
• Identification of key metabolic pathways in *Plasmodium falciparum* as potential targets.

Main Results:

• Significant advancements in understanding malaria parasite biology offer opportunities for new drug development.
• Research in India and globally has identified several promising targets in parasite metabolic pathways.
• Drug resistance patterns underscore the critical need for innovative therapeutic strategies.

Conclusions:

• New pharmacophores derived from parasite-specific metabolic pathways are essential for combating malaria.
• India has the potential to lead in developing affordable antimalarial drugs.
• Increased investment and focus are required to translate research findings into viable treatments for malaria.